Projects per year
Fingerprint
Dive into the research topics where Matthias D'Huyvetter is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
IOF3036: INTEGRAL - Integrating a multimodal approach to address current challenges in immunotherapy
Van Ginderachter, J. (Administrative Promotor), Laoui, D. (CoI (Co-Promotor)), Movahedi, K. (CoI (Co-Promotor)), Hadadi, E. (CoI (Co-Promotor)), Stijlemans, B. (CoI (Co-Promotor)), Raes, G. (CoI (Co-Promotor)), Devoogdt, N. (CoI (Co-Promotor)), Lahoutte, T. (CoI (Co-Promotor)), De Groof, T. (CoI (Co-Promotor)), Goyvaerts, C. (CoI (Co-Promotor)), D'Huyvetter, M. (CoI (Co-Promotor)), Debacker, J. (CoI (Co-Promotor)), Breckpot, K. (CoI (Co-Promotor)), Franceschini, L. (CoI (Co-Promotor)), Raes, G. (Mandate) & Revets, H. (Mandate)
1/01/25 → 31/12/29
Project: Applied
-
FWOIRI10: Research on radioactive nuclei at ISOLDE-CERN, SPIRAL2- GANIL and MEDICIS-CERN
Caveliers, V. (Administrative Promotor) & D'Huyvetter, M. (Co-Promotor)
1/01/23 → 31/12/26
Project: Fundamental
-
HERC59: CASA PETIt: CAmera for Small Animal PET-Imaging
Devoogdt, N. (Administrative Promotor), Raes, G. (Co-Promotor), Lahoutte, T. (Co-Promotor), Van Ginderachter, J. (Co-Promotor), Caveliers, V. (Co-Promotor), Keyaerts, M. (Co-Promotor), Hernot, S. (Co-Promotor) & D'Huyvetter, M. (Co-Promotor)
1/05/22 → 30/04/26
Project: Fundamental
-
FWOSB116: Evaluation of an in vivo pre-targeting approach for targeted radionuclide therapy of cancer using clickable anti-B7-H3 single domain antibodies.
Funeh, C. N. (Mandate), Devoogdt, N. (Administrative Promotor) & D'Huyvetter, M. (Scientific Promotor)
1/11/21 → 31/10/25
Project: Fundamental
-
FWOSB80: Combining targeted radionuclide therapy and cancer immunotherapy to advance precision medicine through innovation.
Breckpot, K. (Administrative Promotor), Devoogdt, N. (Co-Promotor), D'Huyvetter, M. (Co-Promotor), Keyaerts, M. (Co-Promotor) & Ertveldt, T. (Mandate)
1/11/19 → 31/10/23
Project: Fundamental
-
Automated and manual synthesis of [68Ga]Ga-DOTA-4AH29 intended for PET-imaging of FAP-expression
Berdal, M., Nagachinta, S., Langsberg, X., Gaspariunaite, V., Massa, S., Pombo Antunes, A. R., Mantzilas, D., D’Huyvetter, M. & Navarro, L., 1 Dec 2026, In: EJNMMI Radiopharmacy and Chemistry. 11, 1, 18 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Head-to-head comparison of FAP-targeting single-domain antibody 4AH29 vs. peptide FAP-2286
Dumauthioz, N., Navarro, L., Berdal, M., Nagachinta, S., Dewulf, J., Van Eesbeek, M., Plas, S., Pinto, J., Antunes, A. R. P., Mantzilas, D. & D'Huyvetter, M., 13 Feb 2026, In: EJNMMI Research. 16, 1, 13 p., 45.Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus) -
Pharmacokinetics and dosimetry of radiolabeled FAP-targeting single-domain antibody 4AH29 in Göttingen minipigs
Dumauthioz, N., Navarro, L., Berdal, M., Nagachinta, S., Eersels, J., Gaspariunaite, V., Antunes, A. R. P., Dewulf, J., Massa, S., Jørgensen, T., Kristensen, L. K., Starostka, T., Mantzilas, D., Lahoutte, T. & D'Huyvetter, M., 1 Jul 2026, In: Nuclear Medicine and Biology. 158-159, 10 p., 109654.Research output: Contribution to journal › Article › peer-review
Open Access -
Design and Preclinical Validation of an Anti-B7-H3-Specific Radiotracer: A Non-Invasive Imaging Tool to Guide B7-H3-Targeted Therapies
Funeh, C. N., Meeus, F., De Groof, T., D'Huyvetter, M. & Devoogdt, N., 30 Sept 2025, In: Pharmaceuticals. 18, 10, 20 p., 1477.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus)17 Downloads (Pure) -
Efficient α and β- radionuclide therapy targeting fibroblast activation protein-α in an aggressive preclinical mouse tumour model
Ceuppens, H., Pombo Antunes, A. R., Navarro, L., Ertveldt, T., Berdal, M., Nagachinta, S., De Ridder, K., Lahoutte, T., Keyaerts, M., Devoogdt, N., Goyvaerts, C., D'Huyvetter, M. & Breckpot, K., Jan 2025, In: European Journal of Nuclear Medicine and Molecular Imaging. 52, 2, p. 444-457 14 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile15 Citations (Scopus)15 Downloads (Pure)
Datasets
-
DataSet-Targeted Radionuclide Therapy with Low and High-Dose Lutetium-177-Labeled Single Domain Antibodies Induces Distinct Immune Signatures in a Mouse Melanoma Model
Ertveldt, T. (Creator), De Beck, L. (Creator), De Ridder, K. (Creator), Locy, H. (Creator), de Mey, W. (Creator), Goyvaerts, C. (Creator), Lecocq, Q. (Creator), Ceuppens, H. (Creator), De Vlaeminck, Y. (Creator), Awad, R. M. (Creator), Keyaerts, M. (Creator), Devoogdt, N. (Creator), D'Huyvetter, M. (Creator), Breckpot, K. (Creator) & Krasniqi, A. (Creator), Zenodo, 16 Dec 2024
Dataset
Prizes
-
Alavi-Mandell Award from Journal of Nuclear Medicine
Krasniqi, A. (Recipient), D'Huyvetter, M. (Recipient), Devoogdt, N. (Recipient) & Keyaerts, M. (Recipient), 16 Apr 2019
Prize: Prize (including medals and awards)
-
Award of the Fonds Germaine Eisendrath Dubois (FGED)
D'Huyvetter, M. (Recipient), 2012
Prize: Prize (including medals and awards)
-
-
-
Travel Award of Fonds Wetenschappelijk Onderzoek - Vlaanderen (FWO)
D'Huyvetter, M. (Recipient), 7 Sept 2016
Prize: Prize (including medals and awards)
Activities
-
Astatine-211: 'The rarest material on earth is more accessible than you think'.
Sevenois, M. (Speaker), Navarro, L. (Contributor), D'Huyvetter, M. (Contributor) & Covens, P. (Contributor)
26 Apr 2024Activity: Talk or presentation › Talk or presentation at a conference
-
Efficient α and β- radionuclide therapy targeting fibroblast activation protein-α in an aggressive preclinical mouse tumour model.
Ceuppens, H. (Speaker), Pombo Antunes, A. R. (Contributor), Navarro, L. (Contributor), Ertveldt, T. (Contributor), Berdal, M. (Contributor), Nagachinta, S. (Contributor), De Ridder, K. (Contributor), Keyaerts, M. (Contributor), Devoogdt, N. (Contributor), Goyvaerts, C. (Contributor), D'Huyvetter, M. (Contributor) & Breckpot, K. (Contributor)
23 Oct 2024Activity: Talk or presentation › Talk or presentation at a conference
-
Optimization production yield of 211At
Sevenois, M. (Invited speaker), D'Huyvetter, M. (Contributor), Haddad, F. (Contributor) & Covens, P. (Contributor)
10 May 2023Activity: Talk or presentation › Talk or presentation at a workshop/seminar
-
SCK NMA-talk
Ertveldt, T. (Presenter), Devoogdt, N. (Invited speaker) & D'Huyvetter, M. (Contributor)
14 Nov 2023Activity: Talk or presentation › Talk or presentation at a workshop/seminar
-
Optimizing the yield of At-211: Short Term Scientific Mission (STSM) at Arronax institute
Sevenois, M. (Organiser), D'Huyvetter, M. (Contributor), Haddad, F. (Supervisor) & Covens, P. (Supervisor)
22 Aug 2022 → 2 Sept 2022Activity: Other › Research and Teaching at External Organisation
Press/Media
-
Brussels, City of Innovators - Matthias D'Huyvetter
28/01/21
1 Media contribution
Press/Media: Research
-
Camel blood to fight cancer? This VUB spin-off is getting amazing results
Lahoutte, T., Devoogdt, N., D'Huyvetter, M., De Vos, J. & Mebis, C.
17/11/17
1 Media contribution
Press/Media: Research
-
Kanker bestrijden met elektrische fietsjes in het bloed
Lahoutte, T., Devenyns, R., Devoogdt, N., D'Huyvetter, M., De Vos, J. & Mebis, C.
17/10/17
1 Media contribution
Press/Media: Research
-
Lama-antistoffen in strijd tegen kanker
Lahoutte, T., Devoogdt, N., D'Huyvetter, M., De Vos, J. & Mebis, C.
30/03/17
1 Media contribution
Press/Media: Research
-
Thesis
-
CD20 Nb TRNT: targeted radionuclide therapy of non-hodgkin-lymphoma with anti-CD20 nanobodies
Devoogdt, N. (Promotor), D'Huyvetter, M. (Promotor) & Tavernier, J. (Co-promotor), 24 May 2019Student thesis: Doctoral Thesis
-
Characterization of anti-B7-H3 single domain antibody fragments for imaging and targeted radionuclide therapy of cancer
Munir, A. ((PhD) Student), D'Huyvetter, M. (Promotor) & Devoogdt, N. (Co-promotor), Funeh, C. N. (Advisor), 4 Sept 2023Student thesis: Master's Thesis
-
Development and characterization of a novel pan-cancer radiotheranostic agent
Laaniber, M. ((PhD) Student), D'Huyvetter, M. (Promotor) & Devoogdt, N. (Co-promotor), 17 Jun 2022Student thesis: Master's Thesis
-
EGFRvIII Nb TRNT: Evaluation of radiolabeled nanobodies for the treatment of cancers expressing mutant EGFR’
Puttemans, J. ((PhD) Student), Devoogdt, N. (Promotor), D'Huyvetter, M. (Promotor) & Muyldermans, S. (Co-promotor), 4 Mar 2021Student thesis: Doctoral Thesis
-
Evaluation of anti-idiotype Nanobodies in a preclinical model of Multiple Myeloma
Sharma, P. ((PhD) Student), Puttemans, J. (Advisor), Devoogdt, N. (Promotor), D'Huyvetter, M. (Co-promotor) & Muyldermans, S. (Co-promotor), 2019Student thesis: Master's Thesis